PXED

The asset is in a Stage 4 decline with bearish medium-term and long-term biases. Price has decisively broken below key support and is trading extended below declining EMAs, signaling further downside potential. Execution should be deferred until a bounce into the 9- and 21-EMA resistance zone is met with rejection to initiate a trim.

• ↑Adjusted EBITDA rose 7.8% YoY to $34.8M despite a 0.4% revenue dip
• ↑Total degree enrollment reached 82.6k (+1.8% YoY) with retention at 76.6% (+500bps)
• ↓Net revenue declined 0.4% YoY to $222.5M, signaling growth headwinds